Skip to main content

Elevance Health, Inc. cash flow statement

  • ELV · NYSE
  • Insurance
  • Managed Health Care
  • S&P 500
$429.69−0.05%Close 13 Nov 2026 · Market value $96.13B

In fiscal 2025 (the year to 31 Dec 2025), Elevance Health, Inc. generated $4.29B of operating cash flow and $3.17B of free cash flow, after $1.12B of capital expenditure.

From Elevance Health, Inc.'s annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Elevance Health, Inc. cash flow statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Net income$3.35B$2.49B$4.75B$2.89B$2.65B$2.66B$2.49B$2.57B$2.56B$2.47B$3.84B$3.75B$4.81B$4.57B$6.16B$5.89B$5.99B$5.98B$5.66B$5.14B
Depreciation & amortization$410.9M$391.5M$373.1M$344.8M$335.1M$340.1M$353.2M$327.4M$335.9M$296.0M$280.0M$1.13B$1.13B$1.15B$1.30B$1.68B$1.75B$1.39B$1.55B$1.49B
Stock-based compensation$177.1M$156.0M$153.6M$136.0M$134.8M$146.5M$146.0M$168.9M$148.2M$165.0M$170.0M$226.0M$294.0M$283.0M$255.0M$264.0M$289.0M$191.0M$276.0M$240.0M
Operating cash flow$4.34B$2.54B$3.04B$1.42B$3.37B$2.74B$3.05B$3.37B$4.21B$3.27B$4.18B$3.83B$6.06B$10.69B$8.36B$8.40B$8.06B$5.81B$4.29B$7.60B
Operating cash flow margin7.1%4.1%4.7%2.4%5.6%4.5%4.3%4.6%5.3%3.9%4.6%4.2%5.8%8.8%6.0%5.4%4.7%3.3%2.2%3.8%
Capital expenditures$322.0M$345.6M$378.4M$451.4M$519.5M$544.9M$646.5M$714.6M$638.2M$584.0M$791.0M$1.21B$1.08B$1.02B$1.09B$1.15B$1.30B$1.26B$1.12B$1.08B
Acquisitions$298.5M$197.7M$66.30M$300.0K$600.0M$4.60B$0.00$0.00$638.9M$0.00$2.08B$1.76B$0.00$1.98B$3.48B$649.0M$1.55B$4.81B$88.00M$41.00M
Free cash flow$4.02B$2.19B$2.66B$965.3M$2.85B$2.20B$2.41B$2.65B$3.57B$2.69B$3.39B$2.62B$4.98B$9.67B$7.28B$7.25B$6.76B$4.55B$3.17B$6.51B
Free cash flow margin6.6%3.6%4.1%1.6%4.7%3.6%3.4%3.6%4.5%3.2%3.8%2.8%4.8%7.9%5.2%4.6%3.9%2.6%1.6%3.2%
Free cash flow per share$6.69$4.19$5.54$2.32$7.82$6.77$7.92$9.29$13.10$10.02$12.67$9.91$19.15$38.01$29.49$29.85$28.50$19.54$14.13$29.69
Dividends paid———$0.00$357.8M$367.1M$448.0M$480.7M$656.6M$684.0M$705.0M$776.0M$818.0M$954.0M$1.10B$1.23B$1.40B$1.51B$1.53B$1.50B
Gross share repurchases$6.15B$3.28B$2.64B$4.36B$3.04B$2.50B$1.62B$3.00B$1.52B$0.00$2.00B$1.69B$1.70B$2.70B$1.90B$2.32B$2.68B$2.90B$2.60B$2.16B
Stock issuance proceeds$784.5M$121.2M$126.5M$143.6M$245.0M$110.8M$524.7M$301.3M$186.0M$120.0M$225.0M$173.0M$187.0M$176.0M$203.0M$120.0M$87.00M$154.0M$51.00M$118.0M
Net share repurchases$5.37B$3.15B$2.51B$4.22B$2.79B$2.39B$1.10B$2.70B$1.33B−$120.0M$1.77B$1.51B$1.51B$2.52B$1.70B$2.20B$2.59B$2.75B$2.55B$2.04B
Cash interest paid—$443.4M$409.2M$419.6M$432.9M$479.1M$597.2M$575.9M$604.0M$595.0M$778.0M$728.0M$755.0M$794.0M$822.0M$878.0M$1.03B$1.24B$1.41B—
Free cash flow after SBC$3.85B$2.03B$2.51B$829.3M$2.72B$2.05B$2.26B$2.49B$3.43B$2.52B$3.22B$2.39B$4.69B$9.38B$7.02B$6.98B$6.48B$4.36B$2.90B$6.27B

Quarterly

Elevance Health, Inc. cash flow statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Net income$856.0M$2.25B$2.30B$1.02B$418.0M$2.18B$1.74B$1.19B$547.0M$1.76B$1.46B$1.36B
Depreciation & amortization$424.0M$331.0M$335.0M$329.0M$398.0M$373.0M$380.0M$387.0M$406.0M$354.0M$366.0M$363.0M
Stock-based compensation$72.00M$62.00M$92.00M$66.00M−$29.00M$81.00M$81.00M$84.00M$30.00M$55.00M$75.00M$80.00M
Operating cash flow−$2.97B$1.98B$447.0M$2.68B$706.0M$1.02B$2.05B$1.14B$84.00M$4.33B$1.91B$1.27B
Operating cash flow margin−7.0%4.6%1.0%5.9%1.6%2.1%4.1%2.2%0.2%8.6%3.8%2.5%
Capital expenditures$326.0M$279.0M$323.0M$332.0M$322.0M$196.0M$267.0M$360.0M$293.0M$235.0M$287.0M$267.0M
Acquisitions$18.00M$1.12B$4.00M$0.00$3.69B$4.00M$50.00M$1.00M$33.00M$5.00M$0.00$3.00M
Free cash flow−$3.30B$1.70B$124.0M$2.35B$384.0M$821.0M$1.79B$775.0M−$209.0M$4.10B$1.63B$1.00B
Free cash flow margin−7.7%4.0%0.3%5.2%0.8%1.7%3.6%1.5%−0.4%8.2%3.2%1.9%
Free cash flow per share−$13.99$7.25$0.53$10.06$1.66$3.61$7.91$3.46−$0.94$18.59$7.46$4.60
Dividends paid$346.0M$379.0M$378.0M$386.0M$373.0M$386.0M$385.0M$381.0M$377.0M$376.0M$373.0M$373.0M
Gross share repurchases$928.0M$566.0M$463.0M$60.00M$1.81B$880.0M$378.0M$876.0M$471.0M$1.12B$234.0M$330.0M
Stock issuance proceeds$40.00M$97.00M$60.00M$48.00M−$51.00M$23.00M−$2.00M$0.00$30.00M$37.00M$26.00M$25.00M
Net share repurchases$888.0M$469.0M$403.0M$12.00M$1.86B$857.0M$380.0M$876.0M$441.0M$1.09B$208.0M$305.0M
Free cash flow after SBC−$3.37B$1.64B$32.00M$2.28B$355.0M$740.0M$1.71B$691.0M−$239.0M$4.04B$1.55B$920.0M

The main figures as JSON and plain text. See data and methodology.

ELV in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.